(NASDAQ: WBA) Walgreens Boots Alliance's forecast annual revenue growth rate of 1.68% is forecast to beat the US Pharmaceutical Retailers industry's average forecast revenue growth rate of 1.62%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.18%.
Walgreens Boots Alliance's revenue in 2025 is $151,945,000,000.On average, 6 Wall Street analysts forecast WBA's revenue for 2025 to be $130,995,361,804,454, with the lowest WBA revenue forecast at $129,046,092,982,706, and the highest WBA revenue forecast at $133,094,404,094,874. On average, 6 Wall Street analysts forecast WBA's revenue for 2026 to be $132,736,073,139,963, with the lowest WBA revenue forecast at $124,180,645,199,609, and the highest WBA revenue forecast at $136,038,836,637,564.
In 2027, WBA is forecast to generate $139,602,976,676,953 in revenue, with the lowest revenue forecast at $137,882,983,596,742 and the highest revenue forecast at $141,151,685,933,279.